Send to a friend
The details you provide on this page will not be used to send unsolicited email, and will not be sold to a 3rd party. See privacy policy.
The US Centers for Disease Control and Prevention (CDC) has applied for a US patent on the coronavirus that causes severe acute respiratory syndrome (SARS).
But the situation may develop into a full-scale intellectual-property battle between the CDC and other competitors for patent rights, which include the University of Hong Kong and the British Columbia Cancer Agency in Canada.
Link to Nature news in brief
Reference: Nature 423, 214 (2003)
Related SciDev.Net article:
SciDev.Net’s resources on SARS and Developing Countries